Takao T, Tracey D E, Mitchell W M, De Souza E B
Neurobiology Laboratory, National Institute on Drug Abuse, Addiction Research Center, Baltimore, Maryland 21224.
Endocrinology. 1990 Dec;127(6):3070-8. doi: 10.1210/endo-127-6-3070.
The cytokine interleukin-1 (IL-1) has a variety of effects in brain, including induction of fever, alteration of slow wave sleep, and alteration of neuroendocrine activity. To examine the potential sites of action of IL-1 in brain, we used iodine-125-labeled recombinant human interleukin-1 [( 125I]IL-1) to identify and characterize IL-1 receptors in crude membrane preparations of mouse (C57BL/6) hippocampus and to study the distribution of IL-1-binding sites in brain using autoradiography. In preliminary homogenate binding and autoradiographic studies, [125I]IL-1 alpha showed significantly higher specific binding than [125I]IL-1 beta. Thus, [125I]IL-1 alpha was used in all subsequent assays. The binding of [125I]IL-1 alpha was linear over a broad range of membrane protein concentrations, saturable, reversible, and of high affinity, with an equilibrium dissociation constant value of 114 +/- 35 pM and a maximum number of binding sites of 2.5 +/- 0.4 fmol/mg protein. In competition studies, recombinant human IL-1 alpha, recombinant human IL-1 beta, and a weak IL-1 beta analog. IL-1 beta +, inhibited [125I]IL-1 alpha binding to mouse hippocampus in parallel with their relative bioactivities in the T-cell comitogenesis assay, with inhibitory binding affinity constants of 55 +/- 18, 76 +/- 20, and 2940 +/- 742 pM, respectively; rat/human CRF and human tumor necrosis factor showed no effect on [125I]IL-1 alpha binding. Autoradiographic localization studies revealed very low densities of [125I]IL-1 alpha-binding sites throughout the brain, with highest densities present in the molecular and granular layers of the dentate gyrus of the hippocampus and in the choroid plexus. Quinolinic acid lesion studies demonstrated that the [125I]IL-1 alpha-binding sites in the hippocampus were localized to intrinsic neurons. After hypophysectomy, homogenate binding and autoradiographic studies showed that there was no apparent change in the relative density of IL-1 receptors in the hippocampus. The identification of IL-1 receptors in brain with characteristics similar to IL-1 receptors in immune and neuroendocrine tissues provides further support for a physiological role for IL-1 to regulate central nervous system activity.
细胞因子白细胞介素 -1(IL -1)在大脑中具有多种作用,包括引起发热、改变慢波睡眠以及改变神经内分泌活动。为了研究IL -1在大脑中的潜在作用位点,我们使用碘 -125标记的重组人白细胞介素 -1([¹²⁵I]IL -1)来鉴定和表征小鼠(C57BL/6)海马粗膜制剂中的IL -1受体,并使用放射自显影术研究大脑中IL -1结合位点的分布。在初步的匀浆结合和放射自显影研究中,[¹²⁵I]IL -1α显示出比[¹²⁵I]IL -1β显著更高的特异性结合。因此,在所有后续实验中均使用[¹²⁵I]IL -1α。[¹²⁵I]IL -1α的结合在广泛的膜蛋白浓度范围内呈线性,具有饱和性、可逆性且亲和力高,平衡解离常数为114±35 pM,最大结合位点数为2.5±0.4 fmol/mg蛋白。在竞争研究中,重组人IL -1α、重组人IL -1β以及一种弱IL -1β类似物IL -1β⁺,在T细胞增殖试验中与其相对生物活性平行地抑制[¹²⁵I]IL -1α与小鼠海马的结合,抑制性结合亲和常数分别为55±18、76±20和2940±742 pM;大鼠/人促肾上腺皮质激素释放因子(CRF)和人肿瘤坏死因子对[¹²⁵I]IL -1α的结合无影响。放射自显影定位研究显示,整个大脑中[¹²⁵I]IL -1α结合位点的密度非常低,最高密度出现在海马齿状回的分子层和颗粒层以及脉络丛中。喹啉酸损伤研究表明,海马中的[¹²⁵I]IL -1α结合位点定位于内在神经元。垂体切除术后,匀浆结合和放射自显影研究表明,海马中IL -1受体的相对密度没有明显变化。在大脑中鉴定出具有与免疫和神经内分泌组织中IL -1受体相似特征的IL -1受体进一步支持了IL -调节中枢神经系统活动的生理作用。